The Genomics Group of Complex Diseases of the IIB-Sant Pau has been awarded with the Antonio López Borrasca Prize of the Spanish Society of Thrombosis and Hemostasis (SETH) for the research project “Validation of the MIRTO Project: Modeling the Individual Risk of Thrombosis in Oncology”. The award was presented at the XXXIV Congress of the SETH held recently in Granada.
The main objective of the project is to provide health professionals with efficient tools for the diagnosis and prevention of thromboembolic disease in cancer patients.
This multicenter and prospective clinical project has developed a new algorithm to identify cancer patients who will develop venous thromboembolism during the first six months after cancer diagnosis. The group is now awaiting international validation of this algorithm from samples from the prestigious Vienna-CAT study in collaboration with the University of Vienna.